id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-2363-0010,FDA,FDA-2020-E-2363,Notice of Final Determination and Requirement for Election,Other,Letter(s),2024-07-31T04:00:00Z,2024,7,2024-07-31T04:00:00Z,,2024-07-31T12:06:12Z,,0,0,0900006486605ecb
FDA-2020-E-2363-0009,FDA,FDA-2020-E-2363,Letter from FDA CDER to U S Patent and Trademark Office,Other,Letter(s),2023-07-13T04:00:00Z,2023,7,2023-07-13T04:00:00Z,,2023-07-13T16:49:42Z,,0,0,0900006485ca2173
FDA-2020-E-2363-0008,FDA,FDA-2020-E-2363,Determination of Regulatory Review Period for Purposes of Patent Extension; ENSPRYNG; Correction,Notice,Correction,2023-05-24T04:00:00Z,2023,5,2023-05-24T04:00:00Z,,2023-05-24T13:12:34Z,2023-10979,0,0,0900006485a47735
FDA-2020-E-2363-0007,FDA,FDA-2020-E-2363,"Response Letter from FDA CDER to Fish & Richardson, P.C.",Other,Letter(s),2023-05-16T04:00:00Z,2023,5,2023-05-16T04:00:00Z,,2023-05-16T14:27:04Z,,0,0,0900006485a0db46
FDA-2020-E-2363-0006,FDA,FDA-2020-E-2363,Request for Revision of Determination of Regulatory Review Period for Purposes of Patent Extension; ENSPRYNG,Other,Petition(s),2022-09-09T04:00:00Z,2022,9,2022-09-09T04:00:00Z,,2022-09-09T13:49:26Z,,0,0,09000064852cdc6d
FDA-2020-E-2363-0005,FDA,FDA-2020-E-2363,Determination of Regulatory Review Period for Purposes of Patent Extension; ENSPRYNG,Notice,Determinations,2022-07-13T04:00:00Z,2022,7,2022-07-13T04:00:00Z,2022-09-13T03:59:59Z,2023-05-24T13:12:10Z,2022-14930,0,0,09000064851c6d74
FDA-2020-E-2363-0004,FDA,FDA-2020-E-2363,Letter from FDA CDER to U S Patent and Trademark Office,Other,Letter(s),2022-06-14T04:00:00Z,2022,6,2022-06-14T04:00:00Z,,2022-06-14T17:43:26Z,,0,0,0900006485162ed1
FDA-2020-E-2363-0003,FDA,FDA-2020-E-2363,Patent Term Extension Letter from FDA CDER to Honorable Drew Hirshfeld,Other,Extension of Time,2021-03-01T05:00:00Z,2021,3,2021-03-01T05:00:00Z,,2021-03-01T18:59:14Z,,0,0,0900006484a585bd
FDA-2020-E-2363-0001,FDA,FDA-2020-E-2363,Letter from U S Patent and Trademark Office,Other,Letter(s),2020-12-31T05:00:00Z,2020,12,2020-12-31T05:00:00Z,,2020-12-31T14:46:23Z,,0,0,09000064849d6369
FDA-2020-E-2363-0002,FDA,FDA-2020-E-2363,"Patent Term Extension Application for ENSPRYNG® Patent No 10,662,245",Other,Application,2020-12-31T05:00:00Z,2020,12,2020-12-31T05:00:00Z,,2020-12-31T14:47:19Z,,0,0,09000064849d636a